177 related articles for article (PubMed ID: 11004683)
1. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
Berger W; Elbling L; Micksche M
Int J Cancer; 2000 Oct; 88(2):293-300. PubMed ID: 11004683
[TBL] [Abstract][Full Text] [Related]
2. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
4. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells.
Ikeda K; Oka M; Narasaki F; Fukuda M; Nakamura T; Nagashima S; Terashi K; Sato S; Kawabata S; Mizuta Y; Soda H; Kohno S
Anticancer Res; 1998; 18(4C):3077-80. PubMed ID: 9713513
[TBL] [Abstract][Full Text] [Related]
5. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
6. Expression of lung-resistance protein gene is not associated with platinum drug exposure in lung cancer.
Oguri T; Fujiwara Y; Ochiai M; Fujitaka K; Miyazaki M; Takahashi T; Yokozaki M; Isobe T; Ohune T; Tsuya T; Katoh O; Yamakido M
Anticancer Res; 1998; 18(6A):4159-62. PubMed ID: 9891461
[TBL] [Abstract][Full Text] [Related]
7. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
Berger W; Hauptmann E; Elbling L; Vetterlein M; Kokoschka EM; Micksche M
Int J Cancer; 1997 Mar; 71(1):108-15. PubMed ID: 9096673
[TBL] [Abstract][Full Text] [Related]
8. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs.
Izquierdo MA; Scheffer GL; Flens MJ; Shoemaker RH; Rome LH; Scheper RJ
Cytotechnology; 1996; 19(3):191-7. PubMed ID: 8862006
[TBL] [Abstract][Full Text] [Related]
9. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells.
Berger W; Elbling L; Hauptmann E; Micksche M
Int J Cancer; 1997 Sep; 73(1):84-93. PubMed ID: 9334814
[TBL] [Abstract][Full Text] [Related]
11. [Sodium butyrate-induced expression of lung resistance-related gene in human myeloid leukemia K562 cells].
Li N; Qian XH; Yao YM; Wang ZY
Ai Zheng; 2003 Aug; 22(8):821-5. PubMed ID: 12917027
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying lung resistance-related protein (LRP)-mediated doxorubicin resistance of non-small cell lung cancer cells.
Chen YL; Yang TY; Wu CL; Chen KC; Hsu SL; Hsueh CM
Chin J Physiol; 2016 Dec; 59(6):331-347. PubMed ID: 27817195
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
[TBL] [Abstract][Full Text] [Related]
14. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine.
Komarov PG; Shtil AA; Holian O; Tee L; Buckingham L; Mechetner EB; Roninson IB; Coon JS
Oncol Res; 1998; 10(4):185-92. PubMed ID: 9778689
[TBL] [Abstract][Full Text] [Related]
15. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
16. Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.
Meschini S; Marra M; Calcabrini A; Monti E; Gariboldi M; Dolfini E; Arancia G
Toxicol In Vitro; 2002 Aug; 16(4):389-98. PubMed ID: 12110277
[TBL] [Abstract][Full Text] [Related]
17. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
[TBL] [Abstract][Full Text] [Related]
18. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
20. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M
Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
